Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Basurto (43)

2023

  1. Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)

    Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383

2019

  1. Multiple sclerosis: Pregnancy and women's health issues

    Neurologia

2018

  1. Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1109 Neurosciences

    Journal of Neuroinflammation, Vol. 15, Núm. 1

  2. Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial

    Disability and Rehabilitation, Vol. 40, Núm. 2, pp. 208-216

2017

  1. The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis

    Multiple Sclerosis, Vol. 23, Núm. 9, pp. 1276-1288

2016

  1. Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis

    PLoS ONE, Vol. 11, Núm. 8

  2. Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS

    Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569

2015

  1. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

    Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5644-5654

  2. Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

    Clinica Chimica Acta, Vol. 438, pp. 67-69

  3. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

    Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512

  4. Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013

    Neurologia, Vol. 30, Núm. 5, pp. 302-314

  5. FTY720 attenuates excitotoxicity and neuroinflammation

    Journal of Neuroinflammation, Vol. 12, Núm. 1

  6. Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154

  7. Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)

    Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283

  8. Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)

    Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224

2014

  1. Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology

    PLoS ONE, Vol. 9, Núm. 12

  2. Biomarkers in multiple sclerosis: An update for 2014

    Revista de Neurologia, Vol. 58, Núm. 12, pp. 553-570

  3. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

    Revista de Neurologia, Vol. 59, Núm. 7, pp. 307-316

  4. Revisión de las novedades presentadas en el XXIX congreso del comité Europeo para el tratamiento e investigación en esclerosis múltiple (ECTRIMS) (III)

    Revista de Neurologia, Vol. 59, Núm. 8, pp. 371-379

  5. Revisión de las novedades presentadas en el xxix congreso del comité europeo para el tratamiento e investigación en esclerosis múltiple (ECTRIMS) (I)

    Revista de Neurologia, Vol. 59, Núm. 6, pp. 269-280